Pomdoctor Limited
NASDAQPOM, the Nasdaq-listed Pomdoctor Limited, enters the week caught between a sharp one-month rally and a sudden surge in short positioning that has pushed borrow costs to levels rarely seen in small-cap healthcare. The most striking feature of this week's setup is the speed of the short rebuild. Short interest tripled over a five-day window, jumping roughly 200% week-on-week to around…
Short interest % of float, cost to borrow, utilization, and put/call ratio for POM are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 7 May 2026
POM, the Nasdaq-listed Pomdoctor Limited, enters the week caught between a sharp one-month rally and a sudden surge in short positioning that has pushed borrow costs to levels rarely seen in small-cap healthcare. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for POM — free to start on ORTEX.
Sign up for free →Open POM on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live POM data →